Skip to main content

Diagnostic Methods of Cirrhosis and Portal Hypertension: Specifics of the Pediatric Population

  • Chapter
  • First Online:
Diagnostic Methods for Cirrhosis and Portal Hypertension

Abstract

The etiopathogenesis, biology and clinical course of pediatric liver diseases are distinct from that described in adults. There are also critical differences in the availability of disease-specific therapies and evidence supporting surveillance for varices and hepatobiliary cancer in children.

Cirrhosis in children is often a clinical, not histologic, diagnosis and is frequently equated with clinical features of portal hypertension. In light of the general desire to avoid invasive procedures in children, there is enhanced value in developing noninvasive methods to assess advancing fibrosis in children. Evolving preliminary information on noninvasive approaches in children exists, but caution should be exercised in utilization of adult-derived thresholds. Future characterization of these noninvasive approaches will be complicated by the potential inability to universally ground them in histology or portal pressure measurements. As such, correlation with key clinical outcomes will be critical.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Teckman JH, Rosenthal P, Abel R, Bass LM, Michail S, Murray KF, et al. Baseline analysis of a young alpha-1-antitrypsin deficiency liver disease cohort reveals frequent portal hypertension. J Pediatr Gastroenterol Nutr. 2015;61(1):94–101. PubMed PMID: 25651489. Pubmed Central PMCID: 4692167

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Shneider BL, Abel B, Haber B, Karpen SJ, Magee JC, Romero R, Schwarz K, et al. Portal hypertension in children and young adults with biliary atresia. J Pediatr Gastroenterol Nutr. 2012;55:567–73.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman Gerstein M, Piwnica-Worms K, Choyke P, Daryanani KT, et al. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology. 2013;144:112–121.e112.

    Article  PubMed  Google Scholar 

  4. Ye W, Narkewicz M, Leung DH, Karnsakul W, Murray KF, Alonso E, Magee J, et al. Variceal hemorrhage and adverse liver outcomes in patients with cystic fibrosis cirrhosis. J Pediatr Gastrotenterol Nutr. 2017 [Epub ahead of print].

    Google Scholar 

  5. Schwarz KB, Cloonan YK, Ling SC, Murray KF, Rodriguez-Baez N, Schwarzenberg SJ, Teckman J, et al. Children with chronic hepatitis B in the United States and Canada. J Pediatr. 2015;167:1287–1294.e1282.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology. 2008;47:836–43.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Africa JA, Behling CA, Brunt EM, Zhang N, Luo Y, Wells A, Hou J, et al. In children with nonalcoholic fatty liver disease, zone 1 steatosis is associated with advanced fibrosis. Clin Gastroenterol Hepatol. 2017 Mar 7 [Epub ahead of primt].

    Google Scholar 

  8. Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, et al. The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology. 2017;66(2):518–27. PubMed PMID: 28390159

    Article  CAS  PubMed  Google Scholar 

  9. Witters P, Libbrecht L, Roskams T, Boeck KD, Dupont L, Proesmans M, et al. Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology. 2011;53(3):1064–5. PubMed PMID: 21374682

    Article  PubMed  Google Scholar 

  10. Witters P, Libbrecht L, Roskams T, De Boeck K, Dupont L, Proesmans M, et al. Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension. J Cyst Fibros. 2017;16(5):e11–e3. PubMed PMID: 28347603

    Article  PubMed  Google Scholar 

  11. Duche M, Ducot B, Ackermann O, Guerin F, Jacquemin E, Bernard O. Portal hypertension in children: high-risk varices, primary prophylaxis and consequences of bleeding. J Hepatol. 2017;66(2):320–7. PubMed PMID: 27663417

    Article  PubMed  Google Scholar 

  12. Duche M, Ducot B, Tournay E, Fabre M, Cohen J, Jacquemin E, et al. Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding. Gastroenterology. 2010;139(6):1952–60. PubMed PMID: 20637201

    Article  PubMed  Google Scholar 

  13. Shneider BL. Tacit consensus. J Pediatr Gastroenterol Nutr. 2017;64(4):497. PubMed PMID: 28118292

    Article  PubMed  Google Scholar 

  14. Shneider BL, de Ville de Goyet J, Leung DH, Srivastava A, Ling SC, Duche M, et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology. 2016;63(4):1368–80. PubMed PMID: 26358549

    Article  PubMed  Google Scholar 

  15. Hadzic N, Quaglia A, Portmann B, Paramalingam S, Heaton ND, Rela M, et al. Hepatocellular carcinoma in biliary atresia: King's College Hospital experience. J Pediatr. 2011;159(4):617–22.e1. PubMed PMID: 21489554

    Article  PubMed  Google Scholar 

  16. Hirzel AC, Madrazo B, Rojas CP. Two rare cases of hepatocellular carcinoma after Kasai procedure for biliary atresia: a recommendation for close follow-up. Case Rep Pathol. 2015;2015:982679. PubMed PMID: 26339518. Pubmed Central PMCID: 4539070

    PubMed  PubMed Central  Google Scholar 

  17. Kelleher T, Staunton M, O’Mahony S, McCormick PA. Advanced hepatocellular carcinoma associated with cystic fibrosis. Eur J Gastroenterol Hepatol. 2005;17(10):1123–4. PubMed PMID: 16148560

    Article  PubMed  Google Scholar 

  18. McKeon D, Day A, Parmar J, Alexander G, Bilton D. Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis. J Cyst Fibros. 2004;3(3):193–5. PubMed PMID: 15463908

    Article  CAS  PubMed  Google Scholar 

  19. O’Donnell DH, Ryan R, Hayes B, Fennelly D, Gibney RG. Hepatocellular carcinoma complicating cystic fibrosis related liver disease. J Cyst Fibros. 2009;8(4):288–90. PubMed PMID: 19473889

    Article  PubMed  Google Scholar 

  20. Bauman ME, Pound DC, Ulbright TM. Hepatocellular carcinoma arising in congenital hepatic fibrosis. Am J Gastroenterol. 1994;89(3):450–1. PubMed PMID: 8122667

    CAS  PubMed  Google Scholar 

  21. Ghadir MR, Bagheri M, Ghanooni AH. Congenital hepatic fibrosis leading to cirrhosis and hepatocellular carcinoma: a case report. J Med Case Rep. 2011;5:160. PubMed PMID: 21513523. Pubmed Central PMCID: 3105948

    Article  PubMed  PubMed Central  Google Scholar 

  22. Russo P, Magee JC, Boitnott J, Bove KE, Raghunathan T, Finegold M, et al. Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy. Clin Gastroenterol Hepatol. 2011;9(4):357–62.e2. PubMed PMID: 21238606. Pubmed Central PMCID: 3400532

    Article  PubMed  PubMed Central  Google Scholar 

  23. Russo P, Magee JC, Anders RA, Bove KE, Chung C, Cummings OW, et al. Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome: a multicenter study. Am J Surg Pathol. 2016;40(12):1601–15. PubMed PMID: 27776008. Pubmed Central PMCID: 5123664

    Article  PubMed  PubMed Central  Google Scholar 

  24. Duche M, Fabre M, Kretzschmar B, Serinet MO, Gauthier F, Chardot C. Prognostic value of portal pressure at the time of Kasai operation in patients with biliary atresia. J Pediatr Gastroenterol Nutr. 2006;43(5):640–5. PubMed PMID: 17130742

    Article  PubMed  Google Scholar 

  25. Shalaby A, Makin E, Davenport M. Portal venous pressure in biliary atresia. J Pediatr Surg. 2012;47(2):363–6. PubMed PMID: 22325391

    Article  PubMed  Google Scholar 

  26. Woolfson J, John P, Kamath B, Ng VL, Ling SC. Measurement of hepatic venous pressure gradient is feasible and safe in children. J Pediatr Gastroenterol Nutr. 2013;57(5):634–7. PubMed PMID: 23799453

    Article  PubMed  Google Scholar 

  27. Miraglia R, Luca A, Maruzzelli L, Spada M, Riva S, Caruso S, et al. Measurement of hepatic vein pressure gradient in children with chronic liver diseases. J Hepatol. 2010;53(4):624–9. PubMed PMID: 20615572

    Article  PubMed  Google Scholar 

  28. Gana JC, Valentino PL, Morinville V, O’Connor C, Ling SC. Variation in care for children with esophageal varices: a study of physicians’, patients’, and families’ approaches and attitudes. J Pediatr Gastroenterol Nutr. 2011;52(6):751–5. PubMed PMID: 21593647

    Article  PubMed  Google Scholar 

  29. Celinska-Cedro D, Teisseyre M, Woynarowski M, Socha P, Socha J, Ryzko J. Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. J Pediatr Surg. 2003;38(7):1008–11. PubMed PMID: 12861528

    Article  PubMed  Google Scholar 

  30. Goncalves ME, Cardoso SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. J Pediatr Surg. 2000;35(3):401–5. PubMed PMID: 10726678

    Article  CAS  PubMed  Google Scholar 

  31. Ling SC, Walters T, McKiernan PJ, Schwarz KB, Garcia-Tsao G, Shneider BL. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr. 2011;52(3):254–61. PubMed PMID: 21336158. Pubmed Central PMCID: 3728696

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lykavieris P, Chardot C, Sokhn M, Gauthier F, Valayer J, Bernard O. Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology. 2005;41(2):366–71. PubMed PMID: 15660386

    Article  PubMed  Google Scholar 

  33. Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38(3):560–6. PubMed PMID: 12939582

    Article  PubMed  Google Scholar 

  34. Mann JR, Kasthuri N, Raafat F, Pincott JR, Parkes SE, Muir KR, et al. Malignant hepatic tumours in children: incidence, clinical features and aetiology. Paediatr Perinat Epidemiol. 1990;4(3):276–89. PubMed PMID: 2374747

    Article  CAS  PubMed  Google Scholar 

  35. Rawal N, Yazigi N. Pediatric liver transplantation. Pediatr Clin N Am. 2017;64(3):677–84. PubMed PMID: 28502445

    Article  Google Scholar 

  36. Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, et al. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome. Pediatr Transplant. 2006;10(1):42–7. PubMed PMID: 16499586

    Article  CAS  PubMed  Google Scholar 

  37. Romano F, Stroppa P, Bravi M, Casotti V, Lucianetti A, Guizzetti M, et al. Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma. Pediatr Transplant. 2011;15(6):573–9. PubMed PMID: 21797955

    CAS  PubMed  Google Scholar 

  38. Zhang XF, Liu XM, Wei T, Liu C, Li MX, Long ZD, et al. Clinical characteristics and outcome of hepatocellular carcinoma in children and adolescents. Pediatr Surg Int. 2013;29(8):763–70. PubMed PMID: 23794023

    Article  CAS  PubMed  Google Scholar 

  39. Abdelfattah MR, Abaalkhail F, Al-Manea H. Misdiagnosed or incidentally detected hepatocellular carcinoma in explanted livers: lessons learned. Ann Transplant. 2015;20:366–72. PubMed PMID: 26124187

    Article  PubMed  Google Scholar 

  40. Koelink CJ, van Hasselt P, van der Ploeg A, van den Heuvel-Eibrink MM, Wijburg FA, Bijleveld CM, et al. Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer? Mol Genet Metab. 2006;89(4):310–5. PubMed PMID: 17008115

    Article  CAS  PubMed  Google Scholar 

  41. van Ginkel WG, Pennings JP, van Spronsen FJ. Liver cancer in tyrosinemia type 1. Adv Exp Med Biol. 2017;959:101–9. PubMed PMID: 28755188

    Article  PubMed  Google Scholar 

  42. Knisely AS, Strautnieks SS, Meier Y, Stieger B, Byrne JA, Portmann BC, et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology. 2006;44(2):478–86. PubMed PMID: 16871584

    Article  CAS  PubMed  Google Scholar 

  43. Lagana SM, Salomao M, Remotti HE, Knisely AS, Moreira RK. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Histopathology. 2015;66(4):598–602. PubMed PMID: 25378077

    Article  PubMed  Google Scholar 

  44. Almeida P, Schreiber RA, Liang J, Mujawar Q, Guttman OR. Clinical characteristics and complications of pediatric liver biopsy: a single centre experience. Ann Hepatol. 2017;16(5):797–801. PubMed PMID: 28809725

    Article  PubMed  Google Scholar 

  45. Bolia R, Matta J, Malik R, Hardikar W. Outpatient liver biopsy in children: safety, feasibility, and economic impact. J Pediatr Gastroenterol Nutr. 2017;65(1):86–8. PubMed PMID: 28644355

    Article  PubMed  Google Scholar 

  46. Glatz P, Sandin RH, Pedersen NL, Bonamy AK, Eriksson LI, Granath F. Association of anesthesia and surgery during childhood with long-term academic performance. JAMA Pediatr. 2017;171(1):e163470. PubMed PMID: 27820621

    Article  PubMed  Google Scholar 

  47. McCann ME, Soriano SG. General anesthetics in pediatric anesthesia: influences on the developing brain. Curr Drug Targets. 2012;13(7):944–51. PubMed PMID: 22512394. Pubmed Central PMCID: 4172352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Bong CL, Allen JC, Kim JT. The effects of exposure to general anesthesia in infancy on academic performance at age 12. Anesth Analg. 2013;117(6):1419–28. PubMed PMID: 24132012

    Article  CAS  PubMed  Google Scholar 

  49. Wang X, Xu Z, Miao CH. Current clinical evidence on the effect of general anesthesia on neurodevelopment in children: an updated systematic review with meta-regression. PLoS One. 2014;9(1):e85760. PubMed PMID: 24465688. Pubmed Central PMCID: 3896404

    Article  PubMed  PubMed Central  Google Scholar 

  50. Gana JC, Turner D, Roberts EA, Ling SC. Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children. J Pediatr Gastroenterol Nutr. 2010;50(2):188–93. PubMed PMID: 19966576

    Article  PubMed  Google Scholar 

  51. Gana JC, Turner D, Mieli-Vergani G, Davenport M, Miloh T, Avitzur Y, et al. A clinical prediction rule and platelet count predict esophageal varices in children. Gastroenterology. 2011;141(6):2009–16. PubMed PMID: 21925123

    Article  PubMed  Google Scholar 

  52. Witters P, Hughes D, Karthikeyan P, Ramakrishna S, Davenport M, Dhawan A, et al. King’s variceal prediction score: a novel noninvasive marker of portal hypertension in pediatric chronic liver disease. J Pediatr Gastroenterol Nutr. 2017;64(4):518–23. PubMed PMID: 27749613

    Article  CAS  PubMed  Google Scholar 

  53. Leung DH, Khan M, Minard CG, Guffey D, Ramm LE, Clouston AD, et al. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015;62(5):1576–83. PubMed PMID: 26223427

    Article  CAS  PubMed  Google Scholar 

  54. Grieve A, Makin E, Davenport M. Aspartate aminotransferase-to-platelet ratio index (APRi) in infants with biliary atresia: prognostic value at presentation. J Pediatr Surg. 2013;48(4):789–95. PubMed PMID: 23583135

    Article  PubMed  Google Scholar 

  55. Suominen JS, Lampela H, Heikkila P, Lohi J, Jalanko H, Pakarinen MP. APRi predicts native liver survival by reflecting portal fibrogenesis and hepatic neovascularization at the time of portoenterostomy in biliary atresia. J Pediatr Surg. 2015;50(9):1528–31. PubMed PMID: 25783319

    Article  PubMed  Google Scholar 

  56. Pereira TN, Lewindon PJ, Smith JL, Murphy TL, Lincoln DJ, Shepherd RW, et al. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease. J Hepatol. 2004;41(4):576–83. PubMed PMID: 15464237

    Article  CAS  PubMed  Google Scholar 

  57. Honsawek S, Udomsinprasert W, Vejchapipat P, Chongsrisawat V, Phavichitr N, Poovorawan Y. Elevated serum periostin is associated with liver stiffness and clinical outcome in biliary atresia. Biomarkers. 2015;20(2):157–61. PubMed PMID: 25980529

    Article  CAS  PubMed  Google Scholar 

  58. Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179(4):1756–67. PubMed PMID: 21854746. Pubmed Central PMCID: 3181392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Wunsch E, Krawczyk M, Milkiewicz M, Trottier J, Barbier O, Neurath MF, et al. Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases. Sci Rep. 2016;6:30847. PubMed PMID: 27506882. Pubmed Central PMCID: 4978954

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Udomsinprasert W, Honsawek S, Anomasiri W, Chongsrisawat V, Vejchapipat P, Poovorawan Y. Serum autotaxin levels correlate with hepatic dysfunction and severity in postoperative biliary atresia. Biomarkers. 2015;20(1):89–94. PubMed PMID: 25536867

    Article  CAS  PubMed  Google Scholar 

  61. Cook NL, Pereira TN, Lewindon PJ, Shepherd RW, Ramm GA. Circulating microRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2015;60(2):247–54. PubMed PMID: 25625579

    Article  CAS  PubMed  Google Scholar 

  62. Zahm AM, Hand NJ, Boateng LA, Friedman JR. Circulating microRNA is a biomarker of biliary atresia. J Pediatr Gastroenterol Nutr. 2012;55(4):366–9. PubMed PMID: 22732895. Pubmed Central PMCID: 3459263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, et al. Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia. J Pediatr. 2016;170:211–7.e1–2. PubMed PMID: 26725209. Pubmed Central PMCID: 4826612

    Article  CAS  PubMed  Google Scholar 

  64. Bodewes FA, van der Doef HP, Houwen RH, Verkade HJ. Increase of serum gamma-glutamyltransferase associated with development of cirrhotic cystic fibrosis liver disease. J Pediatr Gastroenterol Nutr. 2015;61(1):113–8. PubMed PMID: 25658056

    CAS  PubMed  Google Scholar 

  65. Klotter V, Gunchick C, Siemers E, Rath T, Hudel H, Naehrlich L, et al. Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: results from a prospective longitudinal cohort study. PLoS One. 2017;12(6):e0178784. PubMed PMID: 28575039. Pubmed Central PMCID: 5456384

    Article  PubMed  PubMed Central  Google Scholar 

  66. Aqul A, Jonas MM, Harney S, Raza R, Sawicki GS, Mitchell PD, et al. Correlation of transient elastography with severity of cystic fibrosis-related liver disease. J Pediatr Gastroenterol Nutr. 2017;64(4):505–11. PubMed PMID: 27782957

    Article  PubMed  Google Scholar 

  67. de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007;45(4):443–50. PubMed PMID: 18030211

    Article  PubMed  Google Scholar 

  68. Malbrunot-Wagner AC, Bridoux L, Nousbaum JB, Riou C, Dirou A, Ginies JL, et al. Transient elastography and portal hypertension in pediatric patients with cystic fibrosis transient elastography and cystic fibrosis. J Cyst Fibros. 2011;10(5):338–42. PubMed PMID: 21550861

    Article  CAS  PubMed  Google Scholar 

  69. Shen QL, Chen YJ, Wang ZM, Zhang TC, Pang WB, Shu J, et al. Assessment of liver fibrosis by Fibroscan as compared to liver biopsy in biliary atresia. World J Gastroenterol. 2015;21(22):6931–6. PubMed PMID: 26078570. Pubmed Central PMCID: 4462734

    Article  PubMed  PubMed Central  Google Scholar 

  70. Chongsrisawat V, Vejapipat P, Siripon N, Poovorawan Y. Transient elastography for predicting esophageal/gastric varices in children with biliary atresia. BMC Gastroenterol. 2011;11:41. PubMed PMID: 21501480. Pubmed Central PMCID: 3089784

    Article  PubMed  PubMed Central  Google Scholar 

  71. Siegel MJPA, Bolster B, Kotyk JJ. Pediatric MR elastography of the liver. Clin Pediatr Imaging. 2012:108–11.

    Google Scholar 

  72. Xanthakos SA, Podberesky DJ, Serai SD, Miles L, King EC, Balistreri WF, et al. Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. J Pediatr. 2014;164(1):186–8. PubMed PMID: 24064151. Pubmed Central PMCID: 3872246

    Article  PubMed  Google Scholar 

  73. Schwimmer JB, Behling C, Angeles JE, Paiz M, Durelle J, Africa J, et al. Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease. Hepatology. Epub 2017 May 11. PubMed PMID: 28493388.

    Google Scholar 

  74. Loomba R, Wolfson T, Ang B, Hooker J, Behling C, Peterson M, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology. 2014;60(6):1920–8. PubMed PMID: 25103310. Pubmed Central PMCID: 4245360

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013;268(2):411–9. PubMed PMID: 23564711. Pubmed Central PMCID: 3721049

    Article  PubMed  PubMed Central  Google Scholar 

  76. Etchell E, Juge L, Hatt A, Sinkus R, Bilston LE. Liver stiffness values are lower in pediatric subjects than in adults and increase with age: a multifrequency MR elastography study. Radiology. 2017;283(1):222–30. PubMed PMID: 27755913

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel H. Leung M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Leung, D.H., Finegold, M.J., Shneider, B.L. (2018). Diagnostic Methods of Cirrhosis and Portal Hypertension: Specifics of the Pediatric Population. In: Berzigotti, A., Bosch, J. (eds) Diagnostic Methods for Cirrhosis and Portal Hypertension. Springer, Cham. https://doi.org/10.1007/978-3-319-72628-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72628-1_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72627-4

  • Online ISBN: 978-3-319-72628-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics